A detailed history of Hcr Wealth Advisors transactions in Merck & Co., Inc. stock. As of the latest transaction made, Hcr Wealth Advisors holds 20,947 shares of MRK stock, worth $2.59 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
20,947
Previous 19,981 4.83%
Holding current value
$2.59 Million
Previous $2.18 Million 26.86%
% of portfolio
0.42%
Previous 0.34%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$113.24 - $131.95 $109,389 - $127,463
966 Added 4.83%
20,947 $2.76 Million
Q4 2023

Feb 09, 2024

BUY
$100.18 - $109.02 $24,343 - $26,491
243 Added 1.23%
19,981 $2.18 Million
Q3 2023

Oct 20, 2023

SELL
$102.95 - $114.33 $105,729 - $117,416
-1,027 Reduced 4.95%
19,738 $2.03 Million
Q2 2023

Aug 09, 2023

SELL
$108.61 - $118.38 $10,100 - $11,009
-93 Reduced 0.45%
20,765 $2.4 Million
Q1 2023

May 12, 2023

SELL
$102.94 - $114.86 $113,234 - $126,346
-1,100 Reduced 5.01%
20,858 $2.22 Million
Q4 2022

Feb 13, 2023

SELL
$87.44 - $112.11 $102,217 - $131,056
-1,169 Reduced 5.05%
21,958 $2.44 Million
Q3 2022

Nov 07, 2022

SELL
$84.53 - $94.96 $5,917 - $6,647
-70 Reduced 0.3%
23,127 $2.01 Million
Q2 2022

Aug 12, 2022

SELL
$83.49 - $94.64 $41,077 - $46,562
-492 Reduced 2.08%
23,197 $2.13 Million
Q1 2022

May 05, 2022

SELL
$73.51 - $82.4 $22,641 - $25,379
-308 Reduced 1.28%
23,689 $1.94 Million
Q4 2021

Feb 04, 2022

SELL
$72.28 - $90.54 $13,588 - $17,021
-188 Reduced 0.78%
23,997 $1.84 Million
Q3 2021

Nov 02, 2021

SELL
$71.68 - $78.83 $16,773 - $18,446
-234 Reduced 0.96%
24,185 $1.82 Million
Q2 2021

Jul 21, 2021

SELL
$70.31 - $77.77 $121,847 - $134,775
-1,733 Reduced 6.63%
24,419 $1.9 Million
Q1 2021

May 13, 2021

SELL
$68.86 - $81.11 $252,578 - $297,511
-3,668 Reduced 12.3%
26,152 $2.02 Million
Q4 2020

Feb 04, 2021

BUY
$71.77 - $79.65 $71,052 - $78,853
990 Added 3.43%
29,820 $2.44 Million
Q3 2020

Nov 05, 2020

BUY
$73.18 - $82.95 $85,620 - $97,051
1,170 Added 4.23%
28,830 $2.38 Million
Q2 2020

Jul 30, 2020

SELL
$70.42 - $80.13 $9,858 - $11,218
-140 Reduced 0.5%
27,660 $2.16 Million
Q1 2020

May 08, 2020

BUY
$63.36 - $87.82 $6,209 - $8,606
98 Added 0.35%
27,800 $2.14 Million
Q4 2019

Feb 07, 2020

BUY
$77.58 - $87.54 $310,087 - $349,897
3,997 Added 16.86%
27,702 $2.52 Million
Q3 2019

Nov 07, 2019

SELL
$76.08 - $82.93 $44,354 - $48,348
-583 Reduced 2.4%
23,705 $1.99 Million
Q2 2019

Jul 25, 2019

BUY
$69.84 - $81.59 $21,301 - $24,884
305 Added 1.27%
24,288 $2.04 Million
Q1 2019

May 10, 2019

BUY
$69.58 - $79.36 $136,863 - $156,101
1,967 Added 8.93%
23,983 $1.99 Million
Q4 2018

Jan 31, 2019

BUY
$65.24 - $75.71 $18,201 - $21,123
279 Added 1.28%
22,016 $1.68 Million
Q3 2018

Nov 09, 2018

BUY
$57.69 - $67.84 $11,538 - $13,568
200 Added 0.93%
21,737 $1.57 Million
Q2 2018

Aug 14, 2018

SELL
$50.83 - $59.72 $41,934 - $49,269
-825 Reduced 3.69%
21,537 $1.31 Million
Q1 2018

May 15, 2018

BUY
$50.96 - $59.23 $22,422 - $26,061
440 Added 2.01%
22,362 $1.22 Million
Q4 2017

Feb 13, 2018

BUY
$51.62 - $61.64 $534,163 - $637,850
10,348 Added 89.41%
21,922 $1.23 Million
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $4,928 - $5,302
84 Added 0.73%
11,574 $741,000
Q2 2017

Aug 16, 2017

BUY
N/A
11,490
11,490 $736,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $314B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Hcr Wealth Advisors Portfolio

Follow Hcr Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hcr Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Hcr Wealth Advisors with notifications on news.